1. Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs
   Yu Zhang et al, 2018, Drug Testing and Analysis CrossRef
2. Separation of cordycepin from Cordyceps militaris fermentation supernatant using preparative HPLC and evaluation of its antibacterial activity as an NAD+-dependent DNA ligase inhibitor
   Xiaofeng Zhou et al, 2016, Experimental and Therapeutic Medicine CrossRef
3. Green Chromatography and Related Techniques
   Alshymaa A. Aly et al, 2019, Green Analytical Chemistry CrossRef
4. Overview of therapeutic drug monitoring of immunosuppressive drugs: Analytical and clinical practices
   Behrouz Seyfinejad et al, 2021, Journal of Pharmaceutical and Biomedical Analysis CrossRef
5. Dried blood spot assay for the quantification of phenytoin using Liquid Chromatography-Mass Spectrometry
   Fabio Villanelli et al, 2015, Clinica Chimica Acta CrossRef
6. Issues of Interferences in Therapeutic Drug Monitoring
   Amitava Dasgupta, 2019, Biotin and Other Interferences in Immunoassays CrossRef
7. New insights into liquid chromatography for more eco-friendly analysis of pharmaceuticals
   Heba Shaaban, 2016, Analytical and Bioanalytical Chemistry CrossRef
8. Internal standards in regulated bioanalysis: putting in place a decision-making process during method development
   Michael J Wright et al, 2019, Bioanalysis CrossRef
9. Immunosuppressive drugs in whole blood: validation of a commercially available liquid chromatography/tandem mass spectrometry kit and comparison with immunochemical assays
   Elisa Polledri et al, 2017, Rapid Communications in Mass Spectrometry CrossRef
10. Validation of a novel UPLC‑HRMS method for human whole‑blood cyclosporine and comparison with a CMIA immunoassay
    Xiaoxue Wang et al, 2021, Experimental and Therapeutic Medicine CrossRef
11. Therapeutic drug monitoring of immunosuppressants by liquid chromatography–mass spectrometry
    Adam J. McShane et al, 2016, Clinica Chimica Acta CrossRef
12. Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra-high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminescence microparticle immunoassay
    Shenghui Mei et al, 2018, Journal of Chromatography B CrossRef
13. Intravenous Infusion of Fentanyl Has No Effect on Blood Concentration of Tacrolimus in Patients Receiving Hematopoietic Stem-Cell Transplantation
    Yasuyoshi Ishiwata et al, 2021, Therapeutic Drug Monitoring CrossRef
14. Electrochemical Evaluation of Nitroxyl Radical Catalysts and Electrochemical Detection of Cyclosporin A
    Sachiko Komatsu et al, 2021, International Journal of Electrochemical Science CrossRef
15. Label-free quantification of Tacrolimus in biological samples by atomic force microscopy
    Michele Menotta et al, 2015, Analytica Chimica Acta CrossRef
16. Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations
    Adam B. Cochrane et al, 2020, The Journal of Heart and Lung Transplantation CrossRef
17. A comparison of liquid chromatography-tandem mass spectrometry (LC-MS/MS) and enzyme-multiplied immunoassay technique (EMIT) for the determination of the cyclosporin A concentration in whole blood from Chinese patients
    Wenlong Li et al, 2017, BioScience Trends CrossRef
18. Therapeutic Drug Monitoring in Infants and Children
    Uttam Garg et al, 2016, Clinical Challenges in Therapeutic Drug Monitoring CrossRef
19. Impact of an immunosuppressive human pharmaceutical on the interaction of a bacterial parasite and its invertebrate host
    Lisa Schlüter-Vorberg et al, 2019, Aquatic Toxicology CrossRef